| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Samir K Ballas | |
| Srikanth Nagalla | |||
| P2860 | cites work | Drugs for preventing red blood cell dehydration in people with sickle cell disease | Q24202032 |
| Drugs for preventing red blood cell dehydration in people with sickle cell disease | Q24240777 | ||
| Drugs for preventing red blood cell dehydration in people with sickle cell disease | Q24243611 | ||
| Piracetam for reducing the incidence of painful sickle cell disease crises | Q24245345 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analyses involving cross-over trials: methodological issues | Q29620304 | ||
| Prediction of diltiazem plasma concentration curves from limited measurements using compliance data | Q30978272 | ||
| Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease | Q32061803 | ||
| Use of piracetam improves sickle cell deformability in vitro and in vivo | Q33837500 | ||
| Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. | Q34140614 | ||
| Medroxyprogesterone acetate and homozygous sickle-cell disease | Q34249456 | ||
| Hydroxyurea for sickle cell disease | Q34281892 | ||
| Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia | Q34308407 | ||
| Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients | Q34453137 | ||
| Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia | Q34735496 | ||
| Drugs for preventing red blood cell dehydration in people with sickle cell disease. | Q35041868 | ||
| Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial | Q36112390 | ||
| Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo | Q36115474 | ||
| Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease | Q37352493 | ||
| Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis | Q39285954 | ||
| A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults | Q39299164 | ||
| Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease | Q39643583 | ||
| Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives | Q40333068 | ||
| Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia | Q40668005 | ||
| Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. | Q40818615 | ||
| Volume control in sickle cells is facilitated by the novel anion conductance inhibitor NS1652. | Q40898178 | ||
| Steroid treatment in the prevention of painful episodes in sickle-cell disease | Q40919394 | ||
| A double-blind randomized trial of low-dose oral urea to prevent sickle cell crises | Q41617559 | ||
| Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease | Q41644608 | ||
| Aspartame effect in sickle cell anemia | Q43616694 | ||
| Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder | Q43714655 | ||
| Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity | Q43878404 | ||
| Letter: Plasma-zinc in sickle cell-anaemia | Q43993633 | ||
| Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker se | Q44020318 | ||
| ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice | Q44217786 | ||
| Effects of N-acetylcysteine on dense cell formation in sickle cell disease | Q44407445 | ||
| Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease | Q44787197 | ||
| Therapeutic effect of aspirin in sickle cell anaemia | Q46141928 | ||
| Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia | Q46395706 | ||
| Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease | Q46570854 | ||
| Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia | Q46908502 | ||
| The effect of megestrol acetate on sickling | Q46986366 | ||
| Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline | Q67887927 | ||
| Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients | Q68244250 | ||
| [Effectiveness of treatment during osteoarticular pain crises in drepanocytosis; based on the example of pentoxifylline] | Q68705611 | ||
| Clinical trials of therapy for sickle cell vaso-occlusive crises. Cooperative urea trials group | Q68773992 | ||
| Therapy for sickle cell vaso-occlusive crises. Controlled clinical trials and cooperative study of intravenously administered alkali. Cooperative urea trials group | Q68773994 | ||
| A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis | Q68871469 | ||
| Treatment of sickle cell crisis with urea in invert sugar. A controlled trial. Cooperative urea trials group | Q69344235 | ||
| Inhibition of K transport by divalent cations in sickle erythrocytes | Q69441983 | ||
| Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis | Q69465190 | ||
| Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease | Q69532303 | ||
| Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease | Q69566916 | ||
| Failure of promazine HCl to prevent the painful episodes in sickle cell anemia | Q69848948 | ||
| Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises | Q70386227 | ||
| A double-blind trial of ticlopidine in sickle cell disease | Q70392313 | ||
| Treatment of sickle cell diseases with aspirin | Q70496189 | ||
| Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis | Q70959888 | ||
| Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial | Q71272974 | ||
| Effect of zinc supplementation on serum testosterone level in adult male sickle cell anemia subjects | Q71549693 | ||
| Piracetam is useful in the treatment of children with sickle cell disease | Q71786414 | ||
| A Double-Blind Trial of a Phenothiazine Compound in the Treatment of Clinical Crisis of Sickle Cell Anaemia | Q72413008 | ||
| Effect of dimethyl adipimidate on K+ transport and shape change in red blood cells from sickle cell patients | Q73084568 | ||
| Antisickling activity of sodium cromoglicate in sickle-cell disease | Q73171663 | ||
| RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study | Q73686531 | ||
| Management of patients with sickle cell disease | Q73732175 | ||
| Randomised trial of oral morphine for painful episodes of sickle-cell disease in children | Q73868175 | ||
| The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro | Q74576982 | ||
| Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD) | Q77977136 | ||
| Isoxsuprine in the treatment of sickle cell painful crises: A double-blind comparative study with narcotic analgesic | Q79874689 | ||
| Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial | Q80848296 | ||
| Oral zinc sulphate in sickle-cell ulcers | Q93691263 | ||
| The Effect of Certain Lipid Substances on Sickling | Q93831868 | ||
| Piracetam for the treatment of sickle cell disease in children- a double blind test | Q95543025 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | CD003426 | |
| P577 | publication date | 2018-10-19 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Drugs for preventing red blood cell dehydration in people with sickle cell disease | |
| P478 | volume | 10 |
| Q61813958 | Cancer-Associated Intermediate Conductance Ca-Activated K⁺ Channel K3.1 | cites work | P2860 |
Search more.